United States · FDA National Drug Code directory
Silenor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42847-103_cd7bcf13-11a5-4866-9fd0-da073bb3a9a1
- Product NDC
- 42847-103
- Form
- TABLET
- Composition / generic term
- doxepin hydrochloride
- Labeler
- Currax Pharmaceuticals LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100801
- Source listing expiry
- 20271231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BLISTER PACK (42847-103-03) · 42847-103-03
- 100 TABLET in 1 BOTTLE (42847-103-10) · 42847-103-10
- 30 TABLET in 1 BOTTLE (42847-103-30) · 42847-103-30
- 500 TABLET in 1 BOTTLE (42847-103-50) · 42847-103-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →